Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: Results from Southwest Oncology Group randomized trials
Primo N. Lara, Mary W. Redman, Karen Kelly, Martin J. Edelman, Stephen K. Williamson, John J. Crowley, David R. Gandara
Research output: Contribution to journal › Article › peer-review
165Scopus
citations
Fingerprint
Dive into the research topics of 'Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: Results from Southwest Oncology Group randomized trials'. Together they form a unique fingerprint.